Jun Cai1, Ricardo Gehrau2, Zhenxiao Tu3, Victoria Leroy1, Gang Su1, Junyi Shang1, Valeria R Mas4, Amir Emtiazjoo5, Andres Pelaez5, Carl Atkinson6, Tiago Machuca1, Gilbert R Upchurch1, Ashish K Sharma7. 1. Department of Surgery, University of Florida, Gainesville, Florida. 2. Department of Surgery, University of Virginia, Charlottesville, Virginia. 3. Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina. 4. Transplant Research Institute, Department of Surgery, University of Tennessee, Memphis, Tennessee. 5. Department of Medicine, University of Florida, Gainesville, Florida. 6. Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina; Department of Surgery, Lee Patterson Allen Transplant Immunobiology Laboratory, Medical University of South Carolina, Charleston, South Carolina. 7. Department of Surgery, University of Florida, Gainesville, Florida; Department of Medicine, University of Florida, Gainesville, Florida. Electronic address: ashish.sharma@surgery.ufl.edu.
Abstract
BACKGROUND: Our hypothesis is that the immunomodulatory capacities of mesenchymal stem cell‒derived extracellular vesicles (EVs) can be enhanced by specific microRNAs (miRNAs) to effectively attenuate post-transplant lung ischemia‒reperfusion (IR) injury. METHODS: The expression of miR-206 was analyzed in bronchoalveolar lavage (BAL) fluid of patients on Days 0 and 1 after lung transplantation. Lung IR injury was evaluated in C57BL/6 mice using a left lung hilar-ligation model with or without treatment with EVs or antagomiR-206‒enriched EVs. Murine lung tissue was used for miRNA microarray hybridization analysis, and cytokine expression, lung injury, and edema were evaluated. A donation after circulatory death and murine orthotopic lung transplantation model was used to evaluate the protection by enriched EVs against lung IR injury. In vitro studies analyzed type II epithelial cell activation after coculturing with EVs. RESULTS: A significant upregulation of miR-206 was observed in the BAL fluid of patients on Day 1 after lung transplantation compared with Day 0 and in murine lungs after IR injury compared with sham. Treatment with antagomiR-206‒enriched EVs attenuated lung dysfunction, injury, and edema compared with treatment with EVs alone after murine lung IR injury. Enriched EVs reduced lung injury and neutrophil infiltration as well as improved allograft oxygenation after murine orthotopic lung transplantation. Enriched EVs significantly decreased proinflammatory cytokines, especially epithelial cell‒dependent CXCL1 expression, in the in vivo and in vitro IR injury models. CONCLUSIONS: EVs can be used as biomimetic nanovehicles for protective immunomodulation by enriching them with antagomiR-206 to mitigate epithelial cell activation and neutrophil infiltration in the lungs after IR injury.
BACKGROUND: Our hypothesis is that the immunomodulatory capacities of mesenchymal stem cell‒derived extracellular vesicles (EVs) can be enhanced by specific microRNAs (miRNAs) to effectively attenuate post-transplant lung ischemia‒reperfusion (IR) injury. METHODS: The expression of miR-206 was analyzed in bronchoalveolar lavage (BAL) fluid of patients on Days 0 and 1 after lung transplantation. Lung IR injury was evaluated in C57BL/6 mice using a left lung hilar-ligation model with or without treatment with EVs or antagomiR-206‒enriched EVs. Murine lung tissue was used for miRNA microarray hybridization analysis, and cytokine expression, lung injury, and edema were evaluated. A donation after circulatory death and murine orthotopic lung transplantation model was used to evaluate the protection by enriched EVs against lung IR injury. In vitro studies analyzed type II epithelial cell activation after coculturing with EVs. RESULTS: A significant upregulation of miR-206 was observed in the BAL fluid of patients on Day 1 after lung transplantation compared with Day 0 and in murine lungs after IR injury compared with sham. Treatment with antagomiR-206‒enriched EVs attenuated lung dysfunction, injury, and edema compared with treatment with EVs alone after murinelung IR injury. Enriched EVs reduced lung injury and neutrophil infiltration as well as improved allograft oxygenation after murine orthotopic lung transplantation. Enriched EVs significantly decreased proinflammatory cytokines, especially epithelial cell‒dependent CXCL1 expression, in the in vivo and in vitro IR injury models. CONCLUSIONS: EVs can be used as biomimetic nanovehicles for protective immunomodulation by enriching them with antagomiR-206 to mitigate epithelial cell activation and neutrophil infiltration in the lungs after IR injury.
Authors: Daniel Kreisel; Alexander S Krupnick; Varun Puri; Tracey J Guthrie; Elbert P Trulock; Bryan F Meyers; G Alexander Patterson Journal: J Thorac Cardiovasc Surg Date: 2010-11-19 Impact factor: 5.209
Authors: K Budding; M Rossato; E A van de Graaf; J M Kwakkel-van Erp; T R D J Radstake; H G Otten Journal: Transpl Immunol Date: 2017-04-28 Impact factor: 1.708
Authors: Shamila D Alipoor; Esmaeil Mortaz; Johan Garssen; Masoud Movassaghi; Mehdi Mirsaeidi; Ian M Adcock Journal: Mediators Inflamm Date: 2016-09-25 Impact factor: 4.711
Authors: Donald G Phinney; Michelangelo Di Giuseppe; Joel Njah; Ernest Sala; Sruti Shiva; Claudette M St Croix; Donna B Stolz; Simon C Watkins; Y Peter Di; George D Leikauf; Jay Kolls; David W H Riches; Giuseppe Deiuliis; Naftali Kaminski; Siddaraju V Boregowda; David H McKenna; Luis A Ortiz Journal: Nat Commun Date: 2015-10-07 Impact factor: 14.919
Authors: Samira Mansouri; Himanshu Gogoi; Mauricio Pipkin; Tiago N Machuca; Amir M Emtiazjoo; Ashish K Sharma; Lei Jin Journal: Sci Immunol Date: 2021-07-09